Ventyx biosciences to report first quarter 2023 financial results on may 11, 2023

Encinitas, calif., may 04, 2023 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx), (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that it will report financial results for the first quarter ended march 31, 2023 after market close on may 11, 2023. company management will host a conference call and webcast beginning at 4:30 p.m. et / 1:30 p.m. pt that day to discuss the financial results and highlight recent pipeline and business progress.
VTYX Ratings Summary
VTYX Quant Ranking